Related Experiment Videos
Neuropeptide-processing, -converting, and -inactivating enzymes in human cerebrospinal fluid
1Department of Pharmacology, Uppsala University, Sweden.
International Review of Neurobiology
|January 1, 1988
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The Swedish National Airway Register (SNAR): development, design and utility to date.
European clinical respiratory journal·2020
Developing classification criteria for skin-predominant dermatomyositis: the Delphi process.
The British journal of dermatology·2019
S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).
Journal of the European Academy of Dermatology and Venereology : JEADV·2016
Therapeutic targeting of brain bioenergetics in Alzheimer's disease addressing insulin resistance, glucose hypometabolism, and mitochondrial dysfunction.
International review of neurobiology·2026
Insulin resistance and obesity: Drivers of energy crisis for Alzheimer's disease.
International review of neurobiology·2026
Glial molecular signatures as a liquid biopsy marker in Alzheimer's disease diagnosis.
International review of neurobiology·2026
Metabolic drivers of Alzheimer's disease pathogenesis: Impairments in glucose utilization, lipid homeostasis, and alternative substrate metabolism.
International review of neurobiology·2026
Activation of Nrf2 neuroprotective pathways for treatment of Parkinson's disease: A state of art review.
International review of neurobiology·2026
Metabolic reprogramming in Alzheimer's disease: Interaction between receptor tyrosine kinase signaling, noncoding RNAs, and Neuron-Glia energy networks.
International review of neurobiology·2026
Identifying and investigating emergent behaviour in neural systems.
Frontiers in neuroscience·2026
Optimization of a neuron-microglia co-culture model to explore cell-to-cell interaction dynamics.
Frontiers in immunology·2026
NPTXR as a novel therapeutic target: efficacy of antibody-drug conjugates in preclinical tumor models.
Cancer cell international·2026